EpCAM regulates cell cycle progression via control of cyclin D1 expression.
about
Circulating tumor cells isolation: the "post-EpCAM era"Receptor tyrosine kinases in the nucleusCell adhesion and urothelial bladder cancer: the role of cadherin switching and related phenomenaCirculating and disseminated tumor cells: diagnostic tools and therapeutic targets in motionGene expression correlations in human cancer cell lines define molecular interaction networks for epithelial phenotypePrediction of survival in resected non-small cell lung cancer using a protein expression-based risk model: implications for personalized chemoprevention and therapyAn Ep-ICD based index is a marker of aggressiveness and poor prognosis in thyroid carcinoma.Rapid and non-enzymatic in vitro retrieval of tumour cells from surgical specimens.High EpCAM expression is linked to proliferation and lauren classification in gastric cancer.Regulated intramembrane proteolysis and degradation of murine epithelial cell adhesion molecule mEpCAM.EpCAM and the biology of hepatic stem/progenitor cellsHepatitis B virus X protein induces EpCAM expression via active DNA demethylation directed by RelA in complex with EZH2 and TET2.Soluble EpCAM levels in ascites correlate with positive cytology and neutralize catumaxomab activity in vitro.MMTV/LTR Promoter-Driven Transgenic Expression of EpCAM Leads to the Development of Large Pancreatic IsletsThe Presence of EpCAM(-)/CD49f(+) Cells in Breast Cancer Is Associated with a Poor Clinical OutcomeConfocal laser endomicroscopy in head and neck malignancies using FITC-labelled EpCAM- and EGF-R-antibodies in cell lines and tumor biopsies.Highly tumorigenic hepatocellular carcinoma cell line with cancer stem cell-like propertiesEpithelial cell adhesion molecule regulates tumor initiation and tumorigenesis via activating reprogramming factors and epithelial-mesenchymal transition gene expression in colon cancer.EpCAM overexpression prolongs proliferative capacity of primary human breast epithelial cells and supports hyperplastic growth.Reduction in membranous immunohistochemical staining for the intracellular domain of epithelial cell adhesion molecule correlates with poor patient outcome in primary colorectal adenocarcinomaEpCAM (CD326) is differentially expressed in craniopharyngioma subtypes and Rathke's cleft cystsUrinary EpCAM in urothelial bladder cancer patients: characterisation and evaluation of biomarker potentialFunctional consequences of EpCam mutation in mice and men.Dynamic EpCAM expression on circulating and disseminating tumor cells: causes and consequences.EpCAM-Regulated Transcription Exerts Influences on Nanomechanical Properties of Endometrial Cancer Cells That Promote Epithelial-to-Mesenchymal Transition.Cleavage and cell adhesion properties of human epithelial cell adhesion molecule (HEPCAM).Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment.Replication factor C3 is a CREB target gene that regulates cell cycle progression through the modulation of chromatin loading of PCNA.EpCAM is overexpressed in local and metastatic prostate cancer, suppressed by chemotherapy and modulated by MET-associated miRNA-200c/205.Epithelial cell adhesion molecule is overexpressed in hypopharyngeal carcinoma and suppresses the metastasis and proliferation of the disease when downregulated.B-cell receptor-associated protein 31 regulates human embryonic stem cell adhesion, stemness, and survival via control of epithelial cell adhesion molecule.Context-dependent adaption of EpCAM expression in early systemic esophageal cancer.MMP7 is a target of the tumour-associated antigen EpCAM.Predominant expression of truncated EpCAM is associated with a more aggressive phenotype and predicts poor overall survival in colorectal cancer.Human mesenchymal stem cells preferentially migrate toward highly oncogenic human hepatocellular carcinoma cells with activated EpCAM signaling.An extensive program of periodic alternative splicing linked to cell cycle progression.Epithelial cell adhesion molecule overexpression regulates epithelial-mesenchymal transition, stemness and metastasis of nasopharyngeal carcinoma cells via the PTEN/AKT/mTOR pathway.Spatiotemporal patterning of EpCAM is important for murine embryonic endo- and mesodermal differentiation.Upregulation of LncRNA BCYRN1 promotes tumor progression and enhances EpCAM expression in gastric carcinoma.Hepatitis B Virus-Associated Hepatocellular Carcinoma and Hepatic Cancer Stem Cells.
P2860
Q26778917-04ADECB2-A479-4C31-AAE9-781D699499FDQ26830216-3076A1FF-9F7F-4BB8-A4AA-DB54575E9CA6Q26860953-5E37CBBA-12D5-4F10-8DCC-4DC7E53DE4EFQ28066285-CA43EFAC-BD14-4680-BA7C-31792E1E1DB7Q28539811-A100A554-FF1F-475B-B887-F99A770684D6Q33599090-BD02A19C-FB94-4FAF-8100-C44E192FA068Q34437810-903DE3A9-5C33-43D3-A431-4B75DD531F63Q34576683-8DBC6862-C508-4458-B7C5-B78D14D1CCA9Q34800662-43E85183-EDC6-48CC-A958-B00DD1091652Q34979489-9654E757-A950-4ED8-95C1-C73822299DD9Q35086401-730138B3-6D4C-45BA-9526-4C375C03565AQ35609669-0B1756B5-E193-4EFF-A543-CCF06484AB16Q35623575-128E9BEC-E730-4983-9E6B-7348E833588CQ35932772-185DC786-3C0A-45B7-9C2E-9194C7068666Q36145709-5CF64FA7-0771-4B24-AEA4-C7903788507EQ36255253-04B80B5E-2357-47A2-AE13-B40E59C5AE76Q36267648-C83EB1D2-D30A-47A9-8F56-453F9334D512Q36407948-D231003B-9C4E-4C30-8DB4-E4E8A467032EQ36985597-B66A4E49-7633-4D73-AB55-11CD12F0D606Q36989107-27B0CD28-30F9-49B4-8478-5AAB424C77CDQ37105120-54A39842-7FE9-4F21-832F-72B73E0A20EEQ37558983-46181BC0-5185-4BBA-AC2D-5FC5E2BEE323Q37575826-69AD909F-6EB5-47BB-98A7-8E28AB9048ABQ38237908-9B892658-790B-4ED7-8C34-2BF230ED47E6Q38734383-EBAF90B6-40BE-4CBB-A5E2-E9AF1934CDC0Q38842254-507876B7-FF0C-47DF-A4CD-C8BAE16FDD39Q38844070-5DDB4FD0-102E-43E7-BE39-00B133138768Q38925416-21C81307-1832-4EBB-A918-85BA0C4A218EQ38978361-9EBC4DC8-B291-4555-BCF0-1BBA3C7F2C34Q38981795-ACA12BEB-8061-48C5-A5A1-264721883A92Q38988234-F8489AE2-0CAA-436D-9041-FD26146DA08BQ39076253-1DAA6C64-9D96-45AA-BB3B-25A4FC506C54Q39279697-9BE335EC-4EAE-44D5-BF0A-EBB9A271DBFFQ40842917-BDB92FFD-7979-4228-A9B7-EA762BCA6CD8Q41551195-3638DE3C-7C33-4727-B0D0-97FE3D62E710Q42754639-5DF0DE27-0C75-404D-A604-1FF437348816Q47203446-BEF74A6F-EAFE-4825-907E-4C7715F61BF9Q48147276-56ED8285-528A-4AC4-8023-FBE0EDB757DBQ49536537-B5C35133-EC69-4736-9552-7A4C5CE65485Q52369573-993F7C77-11D3-4A48-97CB-8A79519A043F
P2860
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@en
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@nl
type
label
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@en
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@nl
prefLabel
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@en
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@nl
P2093
P2860
P356
P1433
P1476
EpCAM regulates cell cycle progression via control of cyclin D1 expression.
@en
P2093
P2860
P2888
P304
P356
10.1038/ONC.2012.75
P407
P577
2012-03-05T00:00:00Z